Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
43.73
+0.23 (0.53%)
Feb 9, 2026, 11:28 AM EST - Market open
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $3.1 billion as of February 9, 2026. Its market cap has increased by 43.80% in one year.
Market Cap
3.10B
Enterprise Value
2.67B
1-Year Change
43.80%
Ranking
Category
Stock Price
$43.73
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $3.10B, an increase of 1,278.00%. That is a compound annual growth rate of 73.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.09B | -14.10% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.26B |
| Xenon Pharmaceuticals | 3.20B |
| Alumis | 3.20B |
| Denali Therapeutics | 3.20B |
| Legend Biotech | 3.17B |
| Edgewise Therapeutics | 3.03B |
| Catalyst Pharmaceuticals | 3.02B |
| Disc Medicine | 2.93B |